Mar 09, 2022 04:58 PM (GMT+8) · EqualOcean
Hengrui pharmaceutical announcement that shr-1816 injection has obtained the notice of approval for drug clinical trial. Subcutaneous injection of SHR-1816 is recommended for the treatment of adult diabetes mellitus.